Janice - US: Rheumatoid Arthritis (RA) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Janice is from the United States, and has rheumatoid arthritis (RA) since age 53, about 7 years prior to this interview.  It started as pain in the arch of her feet and toes; X-rays were negative.

Dr David Borenstein, LDN Radio Show 28 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today we are joined by Dr. David Bornstein.  Thank you for joining us, David. 

Dr David Borenstein: Thank you for having me. 

LDN And Rheumatoid Arthritis

MITECHNEWS.COM
30 March 2021
https://mitechnews.com/guest-columns/ldn-and-rheumatoid-arthritis/

Reports from 23andme/CureTogether suggest that LDN (low dose naltrexone) is among the most effective and potent treatments for Rheumatoid Arthritis. Regular and consistent consumption of LDN significantly reduced the need to use other painkillers and disease modifying drugs among Rheumatoid Arthritis patients.
 

Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study

PLoS One
14 February 2019
https://pubmed.ncbi.nlm.nih.gov/30763385/

Dr. Armin Schwarzbach, Infections in Cancer and Autoimmune Disorders. Presented by Markus Berger.

The Benefits of Low Dose Naltrexone

JewishLink
21 May 2020
https://jewishlink.news/monthly-sections/health-link-new/37942-the-benefits-of-low-dose-naltrexone

Sarah Zielsdorf, MD, MS - Rheumatoid Arthritis (2018 Conference) (LDN, low dose naltrexone)

Dr Sarah Zielsdorf shares her presentation on Rheumatoid Arthritis (RA) at The LDN 2018 Conference.

In this presentation Dr Zielsdorf presents a fascinating case study of a patient with Rheumatoid Arthritis (RA) detailing her experience with symptoms, statistics and her own wealth of medical experience.

p>

Sarah Zielsdorf, MD, 2019 Pain Seminar in CT (LDN 2019 Pain Seminar) from LDN Research Trust on Vimeo.

Dr Sarah Zielsdorf shares her presentation on Pain at The LDN 2019 Pain Seminar.

Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Cottel shares case studies of patients:

36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly. 

Jarred Younger, PhD - The Ten Most Important Fibromyalgia Discoveries of 2016 and 2017 (2017 Conference) (LDN, low dose naltrexone)

People with rheumatological conditions are much more likely to have fibromyalgia than the general population, Lupus in particular was indicated to be the most likely rheumatological condition where fibromyalgia was also present.